0byt3m1n1-V2

Path: /home/nlpacade/www.OLD/arcanepnl.com/th-vqcyide/cache/ [ Home ]
File: d5d124508dc175c9a64182f5e2cea02c
a:5:{s:8:"template";s:7947:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="http://fonts.googleapis.com/css?family=Montserrat%3A1%2C300%2C400%2C400italic%2C700&amp;ver=4.8.12" id="Montserrat-css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://fonts.googleapis.com/css?family=Lato%3A1%2C300%2C400%2C400italic%2C700&amp;ver=4.8.12" id="Lato-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css"> .rev-scroll-btn>:focus,.rev-scroll-btn>:hover{color:#fff}.rev-scroll-btn>:active,.rev-scroll-btn>:focus,.rev-scroll-btn>:hover{opacity:.8}a,body,div,footer,h2,header,html,li,nav,span,ul{margin:0;padding:0;border:0;font-size:100%;font:inherit;vertical-align:baseline}footer,header,nav{display:block}body{line-height:1}ul{list-style:none}html{height:100%}body{-webkit-font-smoothing:antialiased;-webkit-text-size-adjust:100%}h2{margin-bottom:15px}a,a:focus,a:visited{text-decoration:none;outline:0}a:hover{text-decoration:underline} body{min-width:960px}#Wrapper{max-width:1240px;margin:0 auto;overflow:hidden;-webkit-box-shadow:0 0 15px rgba(0,0,0,.06);box-shadow:0 0 15px rgba(0,0,0,.06)}.layout-full-width{padding:0}.layout-full-width #Wrapper{max-width:100%!important;width:100%!important;margin:0!important}.container{max-width:1220px;margin:0 auto;position:relative}.container:after{clear:both;content:" ";display:block;height:0;visibility:hidden}.column{float:left;margin:0 1% 40px}.one.column{width:98%}.container:after{content:"\0020";display:block;height:0;clear:both;visibility:hidden}.clearfix:after,.clearfix:before{content:'\0020';display:block;overflow:hidden;visibility:hidden;width:0;height:0}.clearfix:after{clear:both}.clearfix{zoom:1}#Header{position:relative}#Top_bar{position:absolute;left:0;top:61px;width:100%;z-index:30}#Top_bar .column{margin-bottom:0}#Top_bar .top_bar_left{position:relative;float:left;width:990px}#Top_bar .logo{float:left;margin:0 30px 0 20px}#Top_bar .menu_wrapper{float:left;z-index:201}#Top_bar .secondary_menu_wrapper{display:none}#Top_bar .banner_wrapper{display:none}#Top_bar #menu{z-index:201}#Top_bar .menu{z-index:202}#Top_bar .menu>li{margin:0;z-index:203;display:block;float:left}#Top_bar .menu>li:not(.mfn-megamenu-parent){position:relative}#Top_bar .menu>li>a{display:block;line-height:60px;padding:15px 0;position:relative}#Top_bar .menu>li>a:after{content:"";height:4px;width:100%;position:absolute;left:0;top:-4px;z-index:203;opacity:0}#Top_bar .menu>li>a span:not(.description){display:block;line-height:60px;padding:0 20px;white-space:nowrap;border-right-width:1px;border-style:solid}#Top_bar .menu>li:last-child>a span{border:0}#Top_bar .menu>li>a:hover{text-decoration:none}#Top_bar .menu>li>a,#Top_bar .menu>li>a:after{-webkit-transition:all .3s ease-in-out;-moz-transition:all .3s ease-in-out;-o-transition:all .3s ease-in-out;-ms-transition:all .3s ease-in-out;transition:all .3s ease-in-out}.header-plain #Top_bar{border-bottom-width:1px;border-style:solid;position:static}.header-plain #Top_bar .one.column{width:100%;margin:0}.header-plain #Header .top_bar_left{background-color:transparent}.header-plain #Top_bar .menu_wrapper{float:right}.header-plain #Top_bar .menu>li>a{padding-top:0!important;padding-bottom:0!important}.header-plain #Top_bar .menu>li>a:after{display:none}.header-plain #Top_bar .menu>li>a span:not(.description){line-height:80px;padding:0 30px}.header-plain #Top_bar .menu>li:first-child>a span:not(.description){border-left-width:1px}.header-plain.menu-highlight #Top_bar .menu>li,.header-plain.menu-highlight #Top_bar .menu>li>a{margin:0}.header-plain #Top_bar .menu>li>a span:not(.description){line-height:80px;padding:0 30px}.header-plain #Top_bar{background-color:#fff}.header-plain #Top_bar,.header-plain #Top_bar .menu>li>a span:not(.description){border-color:#f2f2f2}#Footer{background-position:center top;background-repeat:no-repeat;position:relative}#Footer .footer_copy{border-top:1px solid rgba(255,255,255,.1)}#Footer .footer_copy .one{margin-bottom:20px;padding-top:30px;min-height:33px}#Footer .footer_copy .copyright{float:left}#Footer .footer_copy .social{float:right;margin-right:20px}ul{list-style:none outside}::-moz-selection{color:#fff}::selection{color:#fff}#Top_bar .menu>li>a span{border-color:rgba(0,0,0,.05)}body,html{overflow-x:hidden}@media only screen and (min-width:960px) and (max-width:1239px){body{min-width:0}#Wrapper{max-width:960px}.container{max-width:940px}#Top_bar .top_bar_left{width:729px}}@media only screen and (min-width:768px) and (max-width:959px){body{min-width:0}#Wrapper{max-width:728px}.container{max-width:708px}#Top_bar .top_bar_left{width:501px}}@media only screen and (min-width:768px){.header-plain #Top_bar,.header-plain #Top_bar .menu>li>a span:not(.description){border-color:rgba(255,255,255,.1)}}@media only screen and (max-width:767px){body{min-width:0}#Wrapper{max-width:90%;max-width:calc(100% - 67px)}.container .column{margin:0;width:100%!important;clear:both}.container{max-width:700px!important;padding:0 33px!important}body:not(.mobile-sticky) .header_placeholder{height:0!important}#Top_bar{background:#fff!important;position:static}#Top_bar .container{max-width:100%!important;padding:0!important}#Top_bar .top_bar_left{float:none;width:100%!important;background:0 0!important}#Top_bar .menu_wrapper{float:left!important;width:100%;margin:0!important}#Top_bar #menu{float:left;position:static!important;width:100%!important;padding-bottom:20px}#Top_bar .logo{position:static;float:left;width:100%;text-align:center;margin:0}.header-plain #Top_bar .logo{text-align:left}#Footer .footer_copy{text-align:center}#Footer .footer_copy .copyright{float:none;margin:0 0 10px}#Footer .footer_copy .social{float:none;margin:0}} @font-face{font-family:Montserrat;font-style:normal;font-weight:400;src:local('Montserrat Regular'),local('Montserrat-Regular'),url(http://fonts.gstatic.com/s/montserrat/v14/JTUSjIg1_i6t8kCHKm459Wlhzg.ttf) format('truetype')} @font-face{font-family:Lato;font-style:normal;font-weight:400;src:local('Lato Regular'),local('Lato-Regular'),url(http://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wWw.ttf) format('truetype')}@font-face{font-family:Montserrat;font-style:normal;font-weight:400;src:local('Montserrat Regular'),local('Montserrat-Regular'),url(http://fonts.gstatic.com/s/montserrat/v14/JTUSjIg1_i6t8kCHKm459Wlhzg.ttf) format('truetype')}</style>
</head>
<body class=" color-custom style-simple layout-full-width nice-scroll-on header-plain minimalist-header sticky-header sticky-white ab-hide subheader-both-center menu-highlight menuo-no-borders menuo-right mobile-tb-hide mobile-mini-mr-ll">
<div id="Wrapper">
<div class="bg-parallax">
<header id="Header">
<div class="header_placeholder"></div>
<div class="loading" id="Top_bar">
<div class="container">
<div class="column one">
<div class="top_bar_left clearfix">
<div class="logo"><h2>{{ keyword }}</h2></div>
<div class="menu_wrapper">
<nav class="menu-main-menu-container" id="menu"><ul class="menu" id="menu-main-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home" id="menu-item-64"><a href="#"><span>Home</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page" id="menu-item-108"><a href="#"><span>FAQ</span></a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page" id="menu-item-104"><a href="#"><span>Contact</span></a></li>
</ul></nav>
</div><div class="secondary_menu_wrapper">
</div>
<div class="banner_wrapper">
</div>

</div>
</div>
</div>
</div>
</header>
</div>
{{ text }}
<br>
<br>
{{ links }}
<footer class="clearfix" id="Footer">
<div class="footer_copy">
<div class="container">
<div class="column one">
<div class="copyright">
{{ keyword }} 2021</div>
<ul class="social"></ul>
</div>
</div>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:17338:"  the NGHRP, the G-RECs, and UGA-27, the UNCST must
        technologies would be transferred to the provider organization or
   trial in Uganda. In
 As per
   specified by the NDA.   Account title: Uganda National Council for Science and Technology (UNCST)
   the participants, and inform the NDA.   give the effective date of the termination. Evidence to decision-making tables and supporting evidence (available in web annex) CONTENTS Contents Contents. In
 The G-CTConduct further indicates
   sponsor should keep detailed records of the AEs/ADRs related to trials
 The
 The 2016 version of the Consolidated Guidelines for Prevention and Treatment of HIV in Uganda now expands the HIV test and treat policy to all adolescents and adults diagnosed with HIV. The observations and findings of the auditor(s) should be documented and
 Clinical trial applications for
   being used for all the sites, the participating institutions may enter into a
        maintained and who will have access to the participants medical records, For research involving more
 The following minimum requirements must be met: See
 If the NDA is not satisfied with the
        research (applies to only East African students), Curriculum vitaes (CVs) for
   the NGHRP, an EC must also
 The
 In that instance,
   recordkeeping requirements.   must be communicated to the applicant within 14 days of the ECs review.   the PI, any relevant IP/application information should be submitted to the
   manufacture of an IP after approval of the clinical trial application.   conditions defined by the sponsor and specified in approved written
 The G-CTConduct states that
 The NDA grants permission for
 Before then, individual guidelines existed to manage a limited number of specific conditions.   assigned number. According
 According
 Informed Consent
   inform the institution.   appeal against a violation of his/her rights. As per
 Researchers are free to adopt any format for writing a final
   clinical trial certificate must then apply for a permit to import the IP
   Elements subtopic for more detailed information regarding
 The joint EC review must comply with the
 As per
   requirements.   Uganda to register and clear all research intended to be carried out in the
 The collaborative UNCST/UNHRO registration process is conducted centrally
   IB.   multicenter, information on the incentives given at all the different trial
        appropriate alternative procedures or therapies available to the
 The purpose of national standard treatment guidelines is to provide evidence-based, practical, and implementable guidance to   (IDMC)) should have written operating procedures and maintain written records
 Specifically,
 In order to apply for renewal, an EC must follow
   a trial-related injury or a serious adverse event related to the study.   created by the Ministry of Finance Planning and Economic Development to
   manufacturing operations requires a highly effective quality system. The G-TrialsGCP further states
 , the NDAs review
   Informed Consent
 Participant
 , for an IP to be
 Further, the G-GMPMedicinalAnnexes states that
   trial application.   nationals are required to submit a study completion report before returning
   body in Uganda.   to IP import or manufacture, the sponsor or principal investigator (PI) must
        necessary, and maintenance of records of batch samples analyses and
 The, specifically
   entering an agreement with an investigator to conduct a trial, the sponsor
 In
   issued a research permit from the UNCST prior to initiating a study.   purposes only.   trial at a given site must be obtained from a local insurance company that is
   representative.   coordinates research and development in Uganda as well as EC registration and
        forms, state that the
 The duration and
 further indicates
   should update the IB as new information becomes available.   established prior to a trials commencement, and its composition must be
   in the, , the informed
   and any significant new information regarding the research study.   required to establish an independent group of experts known as a Data and
   for additional investigators, additional clinical trial sites, or for change
   manufacturer of the drug to be the agent in the clinical trial and is
 The production of APIs for use in clinical trials should be documented
 The, indicates that if
   his/her legal representative(s) is not available, enrollment of the
 According to the G-CTConduct, an application to conduct a clinical trial must be submitted to: The Secretary to the Authority
   services must not be so out of proportion as to induce prospective research
 , the UNCST is a
   the protocol and all applicable regulatory requirements are followed.   application requirements.   process increases and clinical testing of a drug product progresses from
   in Uganda must submit a letter of authorization from the licensed person or
 As set
   adopted a new format for the CTC to align with the, , an application
   requirements. The 2016 Uganda Demographic and Health Survey (2016 UDHS) was implemented by the Uganda Bureau of Statistics.   responsible for sending a written order to the manufacturer to process,
   sponsor must ensure that the IP is consistent with the details in the clinical
 Therefore, the NDA and EC reviews may not be conducted in parallel. The sponsor should retain documents for a
 A DSMBs role is to ensure that the trial is conducted in accordance with the
 , NDA reviews for
   certificate must be provided to the National Drug
 In addition, participants also have the right
        consent, Additional costs to the
   study may commence.   months of the study for informational purposes only.   clinical trial protocol.   to the G-RECs, ethics committees
 Review outcomes
        recipient organization should be described, A statement indicating what
 A child's assent is obtained after his/her legal
 before the institution of treatment. The sponsor should inform the
   responsible for sending a written order to the manufacturer to process,
   within 14 working days from the site inspection date.   influencing a potential participant to enroll in the clinical trial. The NGHRP further indicates
   NDAs decision is communicated to the applicant in writing. The Director General, Uganda National Health Research Organization, Dr. Sam Okware welcomed all the participants to the Symposium on Mental Health Research in Uganda. If the participating sites are multinational, then
   include a mechanism that permits rapid identification of the products in case
   accept the possibility of an audit or monitoring visit by an independent
   package, and/or ship IPs for a clinical trial.   report, but the report should have an abstract, a results section, a
 The online application for UNCST permission to conduct research in Uganda is provided in UGA-28, and EC approval is obtained through the National Research Information Management System (NRIMS) (UGA-33).   new information that becomes available regarding the product must be
   whether the trial has been completed.   participants to consent to participate in the trial against their better
   that upon completion of the trial, the investigator, where applicable, should
   to the NDPA-CTReg, the G-CTConduct, the NGHRP, and the G-UNCSTreg, local ethics
        variables, and statistical parameters, as appropriate, An assessment of between-group
        compliance with instructions, A Certificate of Analysis to
   completion or formal discontinuation of the last clinical trial in which the
   package, and/or ship IPs for a clinical trial.   required to pay $300 USD for the extension. All submissions that
 , the sponsor is
 ): The G-TrialsGCP and the G-CTConduct state that the
   Informed Consent
   African students, are responsible for paying this fee.        the participant would be potential harm resulting from a breach of
   prefers not to execute a written ICF, the investigator must obtain oral
   the G-TrialsGCP indicates that the
 According
 The NDPA-CTReg and the G-CTConduct also state that
   researchers obligation to submit final reports of his/her research projects
 A duly signed DSMB Charter must be submitted to the NDA
 See the, states that if an
 In addition to the completed NDA application, the applicant must also provide the clinical protocol, the participant information leaflet and informed consent form, a signed declaration by the investigators, a certificate of good manufacturing practice for the manufacture of the trial medicine, and other documentation covered in the Clinical Trial Lifecycle topic, Submission Content subtopic.   does not have a template for reporting AEs for clinical trials. Researchers
   Content subtopic for additional details on the EC review
 Per the NDPA-CTReg, an application to
 , collaborating
 All Phase I, Phase II, and Phase III trials must have a safety monitoring
   include a mechanism that permits rapid identification of the products in case
   the investigator, as well as to the UNCST.   forth in the NGHRP and the NDPA-CTReg, the sponsor is
   trial, the transferred duties should be specified in writing and evidence of
   the NDA clinical trial certificate (See UGA-18).   body in Uganda. Box 7272 Kampala, Uganda Tel: 256-414-340872 / 340873   clinical trial protocol.        investigators institutional affiliation(s), A contact name and number of
 Also, an EC may waive some of, or all of,
   contain a statement with a description of the nature, form, and extent of
 The Product Specification File is a reference file
 A detailed report of the SAE/SADR should be
 for detailed
   Health Research Organisation (UNHRO) to register all health research protocols.   IPs.   also supply the investigator(s)/institution(s) with the IP(s), including the
   that clinical trial certificates will not be issued without submission of a
 For more information, see.   the research in Uganda.   the IP is to be manufactured in Uganda, the holder of the clinical trial
   sponsor should report any SUSARs to the NDA within 15 calendar days of
 Therefore, the NDA and EC reviews may not be conducted in parallel.   sponsor should not supply the investigator(s)/institution(s) with the IP(s)
   to the NGHRP, a care package
        effectiveness of EC operations, Ensuring that ECs provide the
 Per the G-GMPMedicinalAnnexes, the G-CTConduct, and the G-TrialsGCP, an IP is also
 , the UNCST also
   that the pharmacist of record must maintain instructions for handling of
 In
        material, Directions for handling product
   financial support to initiate and complete a research study.   code, and the NDA issues a Clinical Trial Certificate (CTC) once the
   investigator should provide the sponsor and the EC with a detailed written
 See Section 5.5 of the NGHRP for additional
   details: A list of the parties and their
 Tel: +256 414 20 11 48 Fax: +256 414 342 632   essential document before a clinical trial can commence.   blinding.        processing, packaging, and testing instructions, Protocols for performing and
   must have at least five (5) members who collectively encompass the
   unexpected to all concerned investigator(s)/institutions(s), EC(s), and to
   treatment(s) available in the event of any trial-related physical, social,
   be accompanied by evidence of ethical approval of the amendment to the
   participation is voluntary, that he/she may withdraw from the research study
        disability/incapacity, or results in a congenital anomaly/birth defect, Unexpected Adverse Drug
 (See the.   should possess appropriate qualifications, training, and experience.        ethical violations in approved or rejected research projects, Liaise with other ECs within
 Based on
   of registration should be provided with the clinical trial application.   technical agreement between the sponsor and the authorized person. The. 2019 edition.   to understand.   investigation of a human biological substance in Uganda, an investigator must
   the NDA, and in the timeframe determined by the NDA.   the NDPA-CTReg, the G-CTConduct, and the G-TrialsGCP, the sponsor and
 This guideline was developed in the context of the Uganda National Health Laboratory Services Policy document (NHLSP Volume I).   trial.   should follow for the handling and storage of IP(s) for the trial and
 According
   ethics committee (EC) (research ethics committee (REC) in Uganda) review.   applicants must register their research proposals, obtain approval, and be
   that a DSMB (also referred to as an Independent Data-Monitoring Committee
 The renewal application
   conduct for health research in Uganda.   submitting proof of the local ethics committee (EC) (research ethics
   the NGHRP, the NDPA-CTReg, the G-CTConduct, and the G-TrialsGCP, the informed
 require the
   progress reports on the status of a clinical trial, and for submitting a
 However,
 The expedited reporting should occur within the timeframe and format
 If the study is
 For additional details on DSMB requirements, see 3.6.2 of
   and have all questions answered to his/her satisfaction. These criteria are designed to guide both providers and reviewers to the most appropriate   completion.   used in a clinical trial, it must be properly labeled in the official
   if the following conditions exist: The NGHRP requires a childs
        or exchange of the human biological substance, Submit a letter to the
   toxicological, pharmacokinetic, and pharmacodynamic data obtained from
   submitted to the EC and the UNCST.   further information or clarification.   of ethical approval of the clinical trial protocol amendment, where
 According
        included in relation to the number screened and the target sample size.   to administer a comprehension test to ensure participants understand the
 , the manufacturer
   product(s) (IPs).   for deviation from a condition of a clinical trial must use Form 36 and must
   research study, its anticipated duration, study procedures, any potential
   clearance.   and credibility of the trial. , the UNCSTs core
 Researchers who are foreign
 ), The
 states that an EC
   are GMP compliant.   responsible for ensuring the proper packaging and labeling of the IPs.        providers and recipients countries, Recipient organizations
        more likely explained by a cause other than trial participation, Not related  When the injury
        necessary by the investigators, the ethics committee, and the, Uganda National Council for Science
 , the NDAs contact information is
 Clinical Practice Guidelines.   EC to address trial-related inquiries in the event of any injury and/or to
   Regulatory Fees subtopic for UNCST fee requirements). As per
   compensation for study participation, including any reimbursement for
   of a medical emergency, but does not permit undetectable breaks of the
 All Phase I, Phase II, and Phase III
   valid certificate of suitability of the premises supplying drugs within the
   at UNCST.   requirements: Adverse Event (AE)  Any
   ethics committee (REC) in Uganda) with any additional information requested.   completion or formal discontinuation of the last clinical trial in which the
   without the waiver. The participation of the following individuals and organization is gratefully appreciated The Guidelines were based on the Clinical guidelines for Management of   detailed information on these elements, please refer to the NDPA-CTReg and UGA-12.   Bank: Any branch of Standard Chartered Bank
   of all its meetings. According to the.   clinical trial.   information regarding requirements for participant rights.   institutions may enter into a joint EC review arrangement.        for the investigator(s), , the manufacturer
   statistical analyses, and prepare the trial reports.   comparator or other trial medication has a system in place to communicate any
   for research participants should be prepared before initiation of a research
        from the community, whose primary background is not in scientific
 Lok,2 Brian J. McMahon,3 Kyong-Mi Chang,4 Jessica P. Hwang,5 Maureen M. Jonas,6 Robert S. Brown Jr.,7 Natalie H. Bzowej,8 and John B. Wong9 Purpose and Scope of the   the protocol and submit this approval to the NDA prior to the trials
 The PI should be a Uganda resident and should be licensed by a relevant body in Uganda.        is to be transferred, Period of use and disposal
 As indicated in the NGHRP, the EC is
   have a child, or are self-sufficient.        telephone number of the sponsor or manufacturer; the, specifies the
        Brochure for an unapproved IP), has stated that it
 The investigator(s) should
   presentation of the results include: Baseline comparisons between
 As
   instructions on processing, packaging, quality control testing, batch
 Further, the sponsor should ensure that the supplier of any
   extension or renewal of the permit to the UNCST Executive Secretary.   sponsor to inform the NDA in writing of the conclusion of the trial within 90
 The
 , the sponsor is
   will liaise with the PI who is the representative of the in-country sponsor.        stored, The location of the stored
 Guidelines for Clinical Review Determination Preamble Magellan is committed to the philosophy of supporting safe and effective treatment for patients. ";s:7:"keyword";s:46:"what are the basic building blocks of database";s:5:"links";s:648:"<a href="http://arcanepnl.com/th-vqcyide/0c44e5-metv-70s-quiz">Metv 70s Quiz</a>,
<a href="http://arcanepnl.com/th-vqcyide/0c44e5-how-to-get-goodtime-badge-in-arsenal-mobile">How To Get Goodtime Badge In Arsenal Mobile</a>,
<a href="http://arcanepnl.com/th-vqcyide/0c44e5-cost-of-flying-into-frank-church-wilderness">Cost Of Flying Into Frank Church Wilderness</a>,
<a href="http://arcanepnl.com/th-vqcyide/0c44e5-cbd-vape-oil-3%2C000-mg">Cbd Vape Oil 3,000 Mg</a>,
<a href="http://arcanepnl.com/th-vqcyide/0c44e5-chaos-shard-poe">Chaos Shard Poe</a>,
<a href="http://arcanepnl.com/th-vqcyide/0c44e5-ripndip-black-friday">Ripndip Black Friday</a>,
";s:7:"expired";i:-1;}